Dow Up 0.21% Nasdaq Down 0.06%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
70.37 Up 1.27(1.84%) 2:30PM EDT - Nasdaq Real Time Price
Prev Close:69.10
Open:68.47
Bid:70.20 x 500
Ask:70.27 x 600
1y Target Est:83.13
Beta:0.55
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:68.12 - 70.90
52wk Range:55.04 - 84.25
Volume:926,346
Avg Vol (3m):1,222,580
Market Cap:10.35B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 1.84%10.35B
FOLDUp 24.29%447.02M
SHPGUp 0.22%48.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.23
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-2.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback